BioSpace News Archive

The global stem cell therapy market size was USD 300 Million in 2021 and is expected to register a revenue CAGR of 16.5% during the forecast period.

The global Real Time Polymerase Chain Reaction (qPCR) market size was USD 4.64 Billion in 2021 and is expected to register a revenue CAGR of 7.8% during the forecast period.

The global NGS-based RNA sequencing market size is expected to reach USD 11.4 Billion in 2030 and register a revenue CAGR of 20.3% during the forecast period.

Ascendis Pharma A/S (Nasdaq: ASND) today disclosed new data from the dose-escalation portion of transcendIT-101, the company’s Phase 1/2 open-label, multi-center trial of TransCon TLR7/8 Agonist in patients with advanced solid tumors.

Founded to address biological aging with gene therapy, BioViva Sciences is broadening its horizons.

The global metabolomics market size was USD 1.88 Billion in 2020 and is expected to register a revenue CAGR of 13.2% during the forecast period.

The global biosurgery market size was USD 11.45 billion in 2020 and is expected to register a revenue CAGR of 5.4% during the forecast period.

Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical stage biopharmaceutical company developing novel viral immunotherapies, today announced presentation of late-breaking data from a phase 1 mechanistic clinical trial of CAN-2409, Candel’s lead viral immunotherapy in development, in combination with nivolumab and standard of care treatment in patients with high-grade glioma.

Immunovia announces its financial calendar for 2023 and 2024.

Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, today presented the first set of preclinical data for its lead oncology mRNA therapeutic, NTX-250, at the 37th annual Society for Immunotherapy of Cancer meeting.